Sponsored Webcast: Pharma 4.0 and Beyond: Getting to the Future State Faster (On Demand)

While other industries have embraced digital transformation and been engaged in end-to-end digitization for a couple decades, ever-important regulatory requirements to ensure patient safety and product quality have provided unique challenges for life sciences to truly transform.

This webcast will explore the future state of technology across pharmaceutical manufacturing and the challenges companies will face. Discussion will then move to what’s going to be required and how life sciences companies can best position themselves – from predictive maintenance to validation requirements – to adopt transformational technologies and drive business value.

Registration Fees & Deadlines

Member: $ 0| Nonmember: $25

Learning Objectives

As technology continues to evolve, what are the most important implications life sciences companies need to consider?

How can life sciences companies best embrace future transformational technologies?

What business value companies can realize through true digital transformation?

Audience Learning Level:

Intermediate: Content is designed based upon the assumption that individuals have basic knowledge of the topic(s) and/or demonstrated competence related to the topic(s). Higher-level concepts are introduced during lectures; exercises requiring synthesis and/or application of concepts are incorporated into the activity.

Who Should Attend?

Life sciences company leaders overseeing manufacturing, compliance, quality, regulatory, IT, GxP systems.

Speakers

Bryan Ennis
Sware, Inc

Bryan is passionate about how we ensure the technology used in healthcare establishes compliance and protects patient safety. He’s an active industry speaker and subject matter expert in life sciences technology, compliance, and the emergence of digital health and AI across the life sciences industry.

Prior to joining Sware, Bryan founded R&D Customer Success at Veeva and led customer retention as Veeva scaled from 3 to 300-plus customers and to $240 million in annual revenue in addition to developing Veeva’s compliance programs to support regulated companies. Before his Veeva days, Bryan was the head of regulatory systems at Genzyme – selecting, implementing, integrating, and validation regulatory content management applications for life sciences.

David Hall Rode
Blue Mountain Quality Resources

David Rode is the CEO of Blue Mountain and serves on its Board of Directors

David has a strong track record of delivering significant revenue growth and financial outcomes.  Many of his career milestones are tied to launching successful GTM programs, building productive, results-oriented teams and orchestrating turnarounds of stagnant businesses as well as accelerating high-growth programs.

Before being named CEO in 2021, David was the CEO of NPact, a SaaS company focused solely on the nonprofit and philanthropic industry and was responsible for all of the company’s worldwide sales and operations, including end-to-end management of NPact’s sales activities, service and support.